Return to homepagePandemic Pact

Project 3 - Ex vivo immune profiling of dengue viruses and vaccines

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 3U19AI118610-06S3

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2021
    2022

  • Known Financial Commitments (USD)

    $152,665

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    PROFESSOR Ana Fernandez-Sesma

  • Research Location

    United States of America

  • Lead Research Institution

    ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

  • Research Priority Alignment

    N/A

  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease surveillance & mapping

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The COVID-19 pandemic is the most important health challenge to the US population within a century. Most epidemiological data have focused on cases that resulted in severe respiratory disease seen predominantly in adults. Inadequate information regarding the infection burden in children is available, especially in the context of households that are prospectively monitored with repetitive testing. This information is critical to determine the silent and symptomatic infection rate in children. The NIAID-supported Human Epidemiology and Response to SARS- CoV-2 (HEROS) survey study is designed to fill this gap.